Pneumonia Management Guidelines

Introduction to Pneumonia

The management of pneumonia requires a structured approach including proper diagnosis, risk assessment, and appropriate antimicrobial therapy based on severity and likely pathogens, as recommended by the American College of Physicians and the American Thoracic Society 1, 2

Community-acquired pneumonia (CAP) is defined as an acute infection of the pulmonary parenchyma with symptoms of acute infection and presence of an infiltrate on chest radiograph or consistent auscultatory findings, according to the Infectious Diseases Society of America 3
Nosocomial pneumonia occurs in hospitalized patients and requires different management approaches than CAP, as stated by the American Thoracic Society 2

Tachypnea is a particularly important vital sign to assess as it correlates with disease severity, as noted by the American College of Physicians 1
Multilobar involvement on chest radiograph is associated with increased severity and poorer prognosis, as reported by the American Thoracic Society 1

The Pneumonia PORT prediction rule stratifies patients into 5 severity classes to guide site-of-care decisions, as developed by the Infectious Diseases Society of America 4, 5
Risk class I (lowest severity): age <50 years, no major comorbidities, normal vital signs and mental status, as defined by the Infectious Diseases Society of America 4, 5
Factors independently associated with increased mortality include comorbidities, signs/symptoms, and laboratory findings, as identified by the Infectious Diseases Society of America 6

For patients without comorbidities: macrolide (azithromycin, clarithromycin), doxycycline, or respiratory fluoroquinolone, as recommended by the American College of Physicians and the American Thoracic Society 1, 2
Empirical therapy should be initiated promptly based on likely pathogens, as stated by the American Thoracic Society 2, 1

Major criteria (any one): need for mechanical ventilation or septic shock requiring vasopressors, as defined by the American Thoracic Society 2
Minor criteria (two or more): systolic BP <90 mmHg, multilobar disease, PaO2/FiO2 ratio <250, as reported by the American Thoracic Society 2

Most patients show clinical improvement within 3-5 days of appropriate therapy, as noted by the American College of Physicians 1
Total duration of therapy is typically 5-7 days for uncomplicated cases, as recommended by the American College of Physicians 1

For patients with suspected drug-resistant S. pneumoniae, consider β-lactams (amoxicillin, cefotaxime, ceftriaxone) as drugs of choice, as recommended by the Infectious Diseases Society of America 3
Pneumococcal vaccination is recommended for at-risk populations, along with annual influenza vaccination and smoking cessation, as stated by the American College of Physicians 1

Collection of blood culture specimens before antibiotic treatment, as recommended by the Infectious Diseases Society of America 3
Institution of antibiotic treatment within 8 hours of hospitalization, as stated by the Infectious Diseases Society of America 3